Rallybio Corp. (RLYB)
16.80
-0.03
(-0.18%)
USD |
NASDAQ |
Aug 24, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Rallybio Price to Book Value : 0.9435 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 0.9452 |
| August 20, 2026 | 0.9323 |
| August 19, 2026 | 0.9547 |
| August 18, 2026 | 0.9418 |
| August 17, 2026 | 0.9547 |
| August 14, 2026 | 0.9542 |
| August 13, 2026 | 0.9525 |
| August 12, 2026 | 0.9317 |
| August 11, 2026 | 0.9199 |
| August 10, 2026 | 0.9328 |
| August 07, 2026 | 0.9075 |
| August 06, 2026 | 0.9092 |
| August 05, 2026 | 0.9064 |
| August 04, 2026 | 0.8963 |
| August 03, 2026 | 0.8958 |
| July 31, 2026 | 0.8946 |
| July 30, 2026 | 0.9025 |
| July 29, 2026 | 0.8963 |
| July 28, 2026 | 0.9073 |
| July 27, 2026 | 0.916 |
| July 24, 2026 | 0.916 |
| July 23, 2026 | 0.9205 |
| July 22, 2026 | 0.9334 |
| July 21, 2026 | 0.9497 |
| July 20, 2026 | 0.9384 |
| Date | Value |
|---|---|
| July 17, 2026 | 0.9221 |
| July 16, 2026 | 0.8963 |
| July 15, 2026 | 0.9059 |
| July 14, 2026 | 0.8991 |
| July 13, 2026 | 0.8924 |
| July 10, 2026 | 0.8834 |
| July 09, 2026 | 0.889 |
| July 08, 2026 | 0.8806 |
| July 07, 2026 | 0.88 |
| July 06, 2026 | 0.8828 |
| July 02, 2026 | 0.8882 |
| July 01, 2026 | 0.8952 |
| June 30, 2026 | 0.8986 |
| June 29, 2026 | 1.690 |
| June 26, 2026 | 1.684 |
| June 25, 2026 | 1.653 |
| June 24, 2026 | 1.675 |
| June 23, 2026 | 1.652 |
| June 22, 2026 | 1.676 |
| June 18, 2026 | 1.680 |
| June 17, 2026 | 1.675 |
| June 16, 2026 | 1.673 |
| June 15, 2026 | 1.673 |
| June 12, 2026 | 1.675 |
| June 11, 2026 | 1.675 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Q32 Bio, Inc. | 3.662 |
| Beam Therapeutics, Inc. | 2.742 |
| C4 Therapeutics, Inc. | 2.043 |
| Cullinan Therapeutics, Inc. | 4.384 |
| Arrowhead Pharmaceuticals, Inc. | 26.30 |
Price to Book Value Related Metrics
| PE Ratio | 2.151 |
| PS Ratio | 145.65 |
| Price to Free Cash Flow | 3.522 |
| Price | 16.80 |
| Earnings Yield | 46.50% |
| Market Cap | 89.16M |
| Normalized PE Ratio | 6.777 |